Artificial intelligence in digital mental health technology: Considerations for regulation

Area of Science:

• Digital mental health technology
• Artificial intelligence in healthcare
• Medical device regulation

Background:

• Artificial intelligence (AI) is increasingly integrated into healthcare, particularly in digital mental health technology (DMHT).
• UK regulatory bodies (MHRA, NICE) are exploring DMHT evaluation and regulation via a Wellcome-funded project.
• A symposium gathered experts to discuss AI in DMHT and inform regulatory approaches.

Purpose of the Study:

• To review key opportunities and challenges of AI in DMHT.
• To focus on the implications for medical device regulation.
• To distill insights from an expert symposium to inform regulatory development.

Main Methods:

• A review of key themes from a symposium involving AI and DMHT experts.
• Analysis of discussions on regulatory and evaluation frameworks for DMHT.
• Synthesis of expert perspectives on responsible innovation.

Main Results:

• AI presents significant opportunities for advancing DMHT.
• Key challenges include ensuring the safety, efficacy, and quality of AI-driven mental health products.
• Agile and adaptive regulatory processes are crucial for this rapidly evolving field.

Conclusions:

• Regulators must continuously adapt processes and guidance to effectively engage with AI in DMHT.
• New initiatives and forums are needed to foster collaboration between innovators and regulators.
• Responsible regulation is essential to enable access to high-quality, safe, and effective AI-powered mental health solutions.